Q1 2025

RESULTS

Hamburg, April 15, 2025 Astrid Hermann, Vincent Warnery

Q1 2025 MEETS EXPECTATIONS

STRONG DERMA

ON TRACK TO REACH FY GUIDANCE

OUTPERFORMANCE CONTINUES

SETTING THE FOUNDATION

INNOVATION & WHITE SPACES

FOR FUTURE SUCCESS IN CHINA

CONTINUE TO FUEL GROWTH

FIRST QUARTER AS EXPECTED FULL YEAR GUIDANCE MAINTAINED

CONSUMER GROUP

+2.3% +3.6%

Q1 2025

NIVEA

DERMA HEALTHCARE LA PRAIRIE

TESA

+2.5% +11.4% +10.8% -17.5%

+10.7%

organic sales growth, NIVEA incl. Labello

NIVEA WITH ROBUST GROWTH

TOUGH Q1 2024 COMPARISON

NIVEA

2024

NIVEA

12.6%

Q1 2025

9.8%

+2.5%

7.9%

5.9%

Q1 Q2 Q3 Q4

organic sales growth, NIVEA incl. Labello

DERMA OUTPERFORMANCE

IN CORE & WHITE SPACES

EUROPE

NORTH

+7.9%

AMERICA

+10.4%

EMERGING

MARKETS

+18.5%

Q1 organic sales growth

FUTURE SUCCESS IN CHINA

SETTING THE FOUNDATION

REFOCUS

TRAVEL

OF NIVEA IN

RETAIL

CHINA

CONSUMER

DESTOCKING

EXCL. GREATER

CHINA

+4.0%

Q1 organic sales growth

FUTURE SUCCESS IN CHINA

THIAMIDOL LAUNCH

LAUNCH

2026

APPROVAL

2024

INNOVATION & WHITE SPACES

CHANTECAILLE

NIVEA INDIA

+15.9%

+31.9%

EPICELLINE

REPURCHASE RATE

FACE USA

2x

+37.2%

COMPETITOR

VS. TOP

Q1 organic sales growth

INNOVATION & WHITE SPACES

NEXT GENERATION PLASTERS

Q1

+10.8%

Q1 2025

FINANCIALS

Attachments

  • Original document
  • Permalink

Disclaimer

Beiersdorf AG published this content on April 15, 2025, and is solely responsible for the information contained herein. Distributed via , unedited and unaltered, on April 15, 2025 at 07:01 UTC.